`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN INSTITUTIONAL INC.,
`Petitioner
`
`v .
`
`FRESENIUS KABI USA, LLC,
`Patent Owner.
`
`U.S. Patent No. 9,168,238 to Jiang et al.
`Issue Date: October 27, 2015
`Title: Levothyroxine Formulations
`
`Inter Partes Review No.: IPR2017-00643
`
`POWER OF ATTORNEY
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`U.S. Patent No. 9,168,238
`
`Pursuant to 37 C.F.R. § 42.10(b), Mylan Institutional Inc., (“Petitioner”)
`
`hereby appoints the practitioners associated with Alston & Bird LLP Customer
`
`Number 00826, including the following lead and backup counsel, as its attorneys
`
`to transact all business in the United States Patent & Trademark Office associated
`
`with the above-captioned Petition for Inter Partes Review of U.S. Patent No.
`
`9,168,238 to Jiang et al. on behalf of Petitioner:
`
`Lead Counsel
`Jitendra Malik, Ph.D.
`Reg. No. 55,823
`ALSTON & BIRD LLP
`4721 Emperor Boulevard, Suite 400
`Durham, North Carolina 27730-8580
`919.862.2200
`jitty.malik@alston.com
`
`Back-Up Counsel
`H. James Abe
`Reg. No. 61,182
`ALSTON & BIRD LLP
`333 South Hope Street, 16th Floor
`Los Angeles, CA 90071
`213.576.1000
`james.abe@alston.com
`
`Lance Soderstrom
`Reg. No. 65,405
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, New York 10016-1387
`212.210.9400
`lance.soderstrom@alston.com
`
`Alissa Pacchioli
`Reg. No. 74,252
`ALSTON & BIRD LLP
`4721 Emperor Boulevard, Suite 400
`Durham, North Carolina 27730-8580
`919.862.2200
`alissa.pacchioli@alston.com
`
`1
`
`
`
`U.S. Patent No. 9,168,238
`
`By:
`
`Name: $
`
`a.wu‘F'
`
`me: Acgpam GWQ CW2 —— 41.2.12 :9
`
`Date:
`
`‘#7/Z037
`
`Mylan Institutional Inc.